Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update (Q41697458)

7 October 2017

Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update (English)

1 reference

7 October 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Laura Cudillo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Andrea Mengarelli

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

Maria Cristina Tirindelli

12 June 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

W Arcese

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

S Santarone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

G De Angelis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

R Cerretti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

E Pennese

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

P Bavaro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

P Olioso

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

T Dentamaro

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

L Cupelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A Chierichini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A Ferrari

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

M Testi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

F Di Piazza

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

P Di Bartolomeo

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Rome Transplant Network

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

English

0 references

publication date

1 June 2015

1 reference

Bone Marrow Transplantation

7 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

50 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

S24-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26039203%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2015.91

12 June 2020

exact match

0 references

cites work

A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Haploidentical bone marrow transplantation without T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

The great debate: haploidentical or cord blood transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

"Designed" grafts for HLA-haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Loss of mismatched HLA in leukemia after stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.91

Anti-leukaemic activity of a novel haploidentical-transplantation approach employing unmanipulated bone marrow followed by CD6-depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemia

21 January 2018

1 reference

12 December 2020

Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

1 reference

12 December 2020

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

1 reference

12 December 2020

T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantati

1 reference

12 December 2020

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

12 December 2020

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

12 December 2020

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process

1 reference

12 December 2020

1994 Consensus Conference on Acute GVHD Grading

1 reference

12 December 2020

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

12 December 2020

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation

1 reference

12 December 2020

Which donor or graft source should you choose for the strongest GVL? Is there really any difference

1 reference

12 December 2020

Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free sur

1 reference

12 December 2020